# Fenofibrate Nanocrystalize

Canonical: https://abierto.us/opportunities/spe2d220r0073

- Solicitation number: SPE2D220R0073
- Notice type: Solicitation
- Status: Awarded to Golden State Medical Supply, Inc.
- Department: Department of Defense
- Agency: Defense Logistics Agency
- Contracting office: DLA Troop Support (SPE2D2)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- First posted: January 9, 2024
- Last posted: January 9, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/983dc145b41f46b3810acc6497292449/view

## Description

Modification P00004 SPE2D2-21-D-0131 No Cost-Settlement Termination for Convenience. Modification P00003 SPE2D2-21-D-0131 to incorporate FAR Claluse 52.204-27 Prohibition on a Bytedance Covered Application (JUN 2023) into contract. Option Year 2 P00002 SPE2D2-21-D-0131 to invoke option period of April 05, 2023 through April 04, 2024. Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023.

Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT. Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.

## Award on USAspending

- Recipient: Golden State Medical Supply, Inc. (UEI GQLDJJ8AQNN5)
- Contract: SPE2D221D0131
- Obligated: $0.00
- Competition: Full and Open Competition, 3 offers received
- Link: solicitation number SPE2D220R0073 equals the FPDS solicitation identifier; same awarding office SPE2D2 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_SPE2D221D0131_9700/


## Publications

- January 9, 2024: Solicitation, due October 23, 2020 at 3:00 PM EDT. Notice 983dc145b41f46b3810acc6497292449. https://sam.gov/workspace/contract/opp/983dc145b41f46b3810acc6497292449/view

## Points of contact

- Phyllis Daraio, Phyllis.Daraio@dla.mil, 2157377941

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/spe2d220r0073.